EPIC |
BVXP |
Sector |
Pharma and Biotech |
ISIN |
GB00B4QVDF07 |
Market Sector |
AIM |
Market Segment |
ASQ1 |
Main Indices |
FTSE AIM All-Share, FTSE AIM 100 |
Country of register |
Great Britain |
Currency |
British Pound |
Market Cap |
£150.21m |
NMS |
200 |
Shares in issue |
5.22m |
Date Listed |
29-Apr-2014 |
|
1st Interim |
2nd Interim |
Ex-Div |
10-Apr-25 |
07-Nov-24 |
Paid |
25-Apr-25 |
21-Nov-24 |
Amount |
70.00p |
87.00p |
11:47 |
46 @ 2,820.00p |
11:46 |
1 @ 2,800.00p |
11:46 |
17 @ 2,900.00p |
11:46 |
0 @ 2,900.00p |
11:46 |
0 @ 2,900.00p |
CEO |
Peter John Harrison |
Chair |
Ian James Nicholson |
CFO |
Bruce Hiscock |
Top of Page
You are here:
research